Nuveen Asset Management, LLC Cara Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.65 $646 - $1,777	1,077 Added 0.95%	113,930 $84,000
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $2,556 - $5,098	-1,531 Reduced 1.34%	112,853 $189,000
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $64,719 - $162,393	-13,235 Reduced 10.37%	114,384 $561,000
Q4 2022 Feb 14, 2023	SELL	$8.88 - $12.77 $181,382 - $260,840	-20,426 Reduced 13.8%	127,619 $1.37 Million
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $92,436 - $140,898	-11,218 Reduced 7.04%	148,045 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $13.84 $1.24 Million - $2.3 Million	-166,488 Reduced 51.11%	159,263 $1.45 Million
Q1 2022 May 16, 2022	SELL	$9.94 - $12.65 $22,722 - $28,917	-2,286 Reduced 0.7%	325,751 $3.9 Million
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $125,871 - $190,433	-10,498 Reduced 3.1%	328,037 $3.86 Million
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $3.02 Million - $4.19 Million	-261,118 Reduced 43.54%	338,535 $5.16 Million
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $195,158 - $460,151	-15,764 Reduced 2.56%	599,653 $8.56 Million
Q1 2021 May 17, 2021	BUY	$15.07 - $21.71 $3.62 Million - $5.22 Million	240,481 Added 64.14%	615,417 $13.4 Million
Q4 2020 Feb 16, 2021	SELL	$12.72 - $16.16 $2.38 Million - $3.02 Million	-186,759 Reduced 33.25%	374,936 $5.67 Million
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $727,714 - $1.06 Million	58,972 Added 11.73%	561,695 $7.15 Million
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $4.14 Million - $5.79 Million	334,015 Added 197.98%	502,723 $8.6 Million
Q1 2020 May 14, 2020	SELL	$9.12 - $17.78 $2,708 - $5,280	-297 Reduced 0.18%	168,708 $2.23 Million
Q4 2019 Feb 14, 2020	SELL	$16.11 - $25.98 $779,546 - $1.26 Million	-48,389 Reduced 22.26%	169,005 $2.72 Million
Q3 2019 Nov 14, 2019	BUY	$18.28 - $26.91 $1.59 Million - $2.35 Million	87,235 Added 67.02%	217,394 $3.97 Million
Q2 2019 Aug 15, 2019	BUY	$17.68 - $21.57 $2.3 Million - $2.81 Million	130,159 New	130,159 $2.8 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

Vanguard Group Inc Valley Forge, PA

2.25M
Shares

$10.3 Million
0.0% of portfolio
Chescapmanager LLC Baltimore, MD

1.7M
Shares

$7.83 Million
0.06% of portfolio
Farallon Capital Management LLC San Francisco, CA

1.56M
Shares

$7.16 Million
0.0% of portfolio
Disciplined Growth Investors Inc Minneapolis, MN

1.11M
Shares

$5.12 Million
0.01% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.11M
Shares

$5.1 Million
0.0% of portfolio

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $247M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account